🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Rationale and Design of NUDGE-CKD: A Nationwide Randomized Factorial Trial of Electronic Nudges for Increasing Guideline-Directed Medical Therapy in Chronic Kidney Disease From Tor Biering-Sørensen, MD, MSc, MPH, PhD and team: sciencedirect.com/science/articl…

An #AI algorithm for interpreting #ECG can identify individuals with subclinical #HeartFailure when #cvEcho isn’t widely available, new research suggests. TCTMD explores the latest findings: bit.ly/4kpOVVt

FINEARTS-HF is the 2nd large RCT to include patients with #HFimpEF. Out now🚨 our new JAMA Cardiology analysis shows that finerenone confers benefit in this group, despite their persistent risk of adverse outcomes jamanetwork.com/journals/jamac… Muthu Vaduganathan scottdavidsolomon orlyvardeny

Finerenone in Heart Failure with Improved Ejection Fraction in #FINEARTSHF led by Maria A. Pabón, MD in JAMA Cardiology jamanetwork.com/journals/jamac…

Great week at St Boniface Hospital. The Cardiac Sciences Manitoba structural team randomized 🇨🇦's 1st pt into the EMPOWER trial! RCT of Carillon Mitral Contour System. 🙏 u to Prof Peter Nordbeck (Germany) +Kristy Kimball from Cardiac Dimensions Great team of Malek Kass AshishShah

Turning wearable data into tomorrow’s heart failure prognosis —welcome to the future of care. University Health Network Apple Women in Heart Transplantation and MCS Temerty Centre for AI in Medicine (T-CAIREM) Greg Lewis The ISHLT Eric Topol HFSA ACTION HF Collaboratory

Join us in spreading vital awareness this Hypertension Awareness Month! 🌍🎙️ Tune in to my podcast with Prof. Ian Wilkinson President of the British and Irish Hypertension Society Let's equip our patients with knowledge. Share this episode with your patients Find BEATWISE the podcast on all

Most viewed this week from JAMA Cardiology: Patients with heart failure and HFimpEF remain at high risk for cardiovascular events, but finerenone consistently reduces this risk without significant adverse effects. ja.ma/4mA4snK

🌟 Investigator Spotlight: Dr. Diana Foo on Heart2Miss 🌟 𝑯𝒆𝒂𝒓𝒕2𝑴𝒊𝒔𝒔, an AI-supported cardiac ultrasound triage programme for early heart failure (HF) detection in Malaysia, was featured on the main stage at #HeartFailure2025 — recognised for its innovative,

Several analyses from global #RCTs document high clinical risk after **outpatient** #WHF events. What about 🇺🇸 clinical practice? What about💵 costs for inpatient vs outpatient #WHF? 🔥 New data from #GWTG_HF AHA Science now in European Society of Cardiology Journals #EJHF 🔗onlinelibrary.wiley.com/doi/epdf/10.10…

Huge congrats to Amanda Jowell MGH IM Residents for receiving a top resident abstract award for her analysis of female-specific CVD risk factors in severe hypercholesterolemia 🏆 Mass General Heart MGH Cardiovascular Research Center MGH Corrigan Women's Heart Health Program

So grateful to have the opportunity to present our work! Thank you to Michael Honigberg, MD, MPP for the incredible mentorship and support!

📣 In this Friday's PCT Grand Rounds, Ankeet Bhatt Ankeet S. Bhatt, MD, MBA of the Kaiser Permanente Division of Research Kaiser Permanente Research NorCal will discuss the KP-VACCINATE megatrial and embedding randomization into clinical care. Join us! #pctGR 🔗 duke.is/pctnews20250530

⏳This marks the end of six life changing weeks Brigham and Women's Hospital #Boston ♥️I am full of gratitude for the opportunity to work with the amazing scottdavidsolomon Muthu Vaduganathan Safia Chatur, MD Maria A. Pabón, MD Jon Cunningham 💸 Thank you British Cardiovascular Society Heart Research UK for this opportunity

In this📑we 💥map 🌎regions over/underrepresented in pivotal HF #RCTs relative to Dz 💥show that regional disparities in participant #enrolment are related to regional #disparities in site recruitm’t Estimating Site #RepresentationIndex pre trial can help doi.org/10.1002/ejhf.3…

#CONFIDENCE built-in randomized withdrawal phase (after 180d of therapy) Reassuringly, early effects of combination therapy on: hemodynamics (BP lowering) electrolytes (K+ increase) kidney function (eGFR “dip”) all rapidly & fully reversible after drug cessation in just 30d!

Congratulations Isabela on your well deserved award!

🧵1/📌 New insights from the FINEARTS-HF trial published in JAMA Cardiology: 💊 Finerenone shows consistent benefits in patients with HFmrEF & HFpEF — regardless of frailty status. #CardioTwitter #HeartFailure #Frailty #Finerenone #HFmrEF #HFpEF 2/ 👴 Frailty is common in HF

HFimpEF is on the rise, but recovery isn’t the end of the story. Our latest review dives into what we know (and don’t) about its prognosis, treatment, and outcomes jacc.org/doi/full/10.10…

New tech alert! A wearable sensor (CardioTag) + advanced ML model estimates Pulmonary Capillary Wedge Pressure, key for heart failure, non-invasively. Tested against invasive measures, it showed strong correlation, opening doors for remote HF management sciencedirect.com/science/articl…